Drug policy 101: Kaiser Permanente’s Approach to Pharmaceutical Detailing
As patients, providers, and health systems continue to grapple with unsustainably high drug prices in the United States, it is…
Biosimilars at Kaiser Permanente
Biosimilars play a critical role in lowering drug prices. Kaiser Permanente successfully uses biosimilars to improve affordability for our members.…
The Medicaid Drug Rebate Program and the impact of “best price” rules
The Medicaid Drug Rebate Program (MDRP) requires pharmaceutical manufacturers to issue rebates to Medicaid for covered outpatient drugs. When they…
Maintaining social connection in a time of physical distance
The arrival of the novel coronavirus has raised unprecedented challenges across the globe. In our collective effort to help flatten…
Drug policy 101: Pharmaceutical marketing tactics
Pharmaceutical marketing aims to shape both patient and clinician perceptions about a drug’s benefit and can significantly impact patient and…
Drug policy 101: Breaking down different types of drug products
As patients, providers, and health systems continue to grapple with unsustainably high drug prices in the United States, it is…
Drug policy 101: Biosimilars
Biologics — drugs derived from living organisms that are used to treat conditions such as rheumatoid arthritis, multiple sclerosis, and…
